Live Breaking News & Updates on Lysatpharma Gmbh

Stay updated with breaking news from Lysatpharma gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Portfolio company Lysatpharma and joint venture Novaxomx start with research and product development

Xlife Sciences AG / Key word(s): MiscellaneousPortfolio company Lysatpharma and joint venture Novaxomx start with research and product development in biosurgical treatment therapies 01.12.2022 / 07:01 CET/CESTLysatpharma, a portfolio company of Xlife Sciences (SIX: XLS), and Novaxomx, a joint-venture of Xlife Scienc. ....

Lysatpharma Gmb , Dirk Dembski , Dennis Lennartz , Valentin Handschin , Xlife Sciences Ag Key , Xlife Sciences , Stock Exchange , Swiss Exchange , Chief Scientific Officer , Managing Director , Lysatpharma Gmbh , Year Report ,